On December 13, 2016, President Obama signed into law the 21st Century Cures Act (Cures Act). While much of the focus has been on policies intended to accelerate drug and device development and approval, the Cures Act also includes numerous provisions impacting the Medicare and Medicaid programs, such as Medicare long-term care hospital (LTCH), infusion drug reimbursement, and durable medical equipment (DME) policies, among many others. Furthermore, the Cures Act once again expands the federal government's fraud and abuse authorities by adding new penalties for various offenses involving Department of Health and Human Services (HHS) grants.
This Client Alert focuses on the major Medicare and Medicaid provisions of the Cures Act. The drug and device development and approval provisions will be addressed in a separate alert. Our recent blog post examined additional provisions in the Cures Act that address mental health and substance abuse policies and fund programs to combat opioid abuse.
Download the PDF to learn more!
Medicare, Medicaid Payment Policies, Fraud Authorities Enacted as Part of 21st Century Cures Act
This article is presented for informational purposes only and is not intended to constitute legal advice.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.